Full Press Release Details
Lexicon Pharmaceuticals Announces Two Presentations at the American College of Cardiology's 70th Annual Scientific Session.
LXRX
Lexicon Pharmaceuticals Announces Two Presentations at the American College of Cardiology's 70th Annual Scientific Session
Key Takeaway: Lexicon Pharmaceuticals Announces Two Presentations at the American College of Cardiology's 70th Annual Scientific Session
BiopharmaWatch Analysis
From our catalyst data and publicly available data · not financial adviceBest trade, last catalyst
+111%
120-day peak, hindsight
Typical move
11%
average across 13 past catalysts
Cash runway
~61 mo
Minimal dilution risk
Lead asset
Sotagliflozin
Phase 3 · Type 1 Diabetes Mellitus